7 hrs ago | The Post Chronicle
New Thoratec Heart Pump Beats Older Model In Study
Advanced heart failure patients who received Thoratec Corp's new pump awaiting U.S. approval as an alternative to heart transplants lived longer and fared far better than those getting the company's older HeartMate XVE device, researchers said on Tuesday.
15 hrs ago | Medical News
Medtronic launches an educational campaign to raise awareness of overactive bladder
Medtronic, Inc. today announced the kick-off of an educational campaign aimed at raising awareness among women of overactive bladder , a serious condition that can severely impact patients' lives.
Chinese Fosun Pharma rises on acquisition deal
Shanghai Fosun Pharmaceuticals Co., or Fosun Pharma, rises slightly Thursday morning at the Shanghai Stock Exchange after it announced to have bought stake in the Nasdaq-listed Chindex International Inc.
OraSure Settles HIV Test Patent Lawsuit
OraSure Technologies Inc., which makes diagnostic kits to detect HIV and drug use, said Thursday it will pay Inverness Medical $3 million to settle a patent dispute over HIV tests.
Destination Therapy Trial Data Demonstrate Superiority For HeartMate II(R) Over HeartMate(R) XVE
Thoratec Corporation , a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said that data released from the Destination Therapy pivotal trial for the HeartMate II left ventricular assist system demonstrate that the device achieved statistically superior results over the HeartMate XVE, ...
New resuscitation program shows major improvement in patient outcome after cardiac arrest
ZOLL Medical Corporation announced today that in a a oeBest of the Besta presentation at the American Heart Association Resuscitation Science Symposium in Orlando Florida, Daniel P. Davis, M.D., presented research from the University of California Resuscitation Research Center that shows a major improvement in patient outcome after cardiac arrest.
Delcath Systems Share Offering Raises $32 Million
Delcath Systems Inc., a developer of a cancer-drug delivery device, said Wednesday it raised $32.4 million in net proceeds from a public stock offering.
Drilling co. ordered to give up employment records
A Houston-based oil and gas drilling company facing complaints of racial discrimination has been ordered to turn over its personnel records as part of an Equal Employment Opportunity Commission investigation.
Medtronic Gets FDA Warning on Heart Implant Unit
FILE - In this Aug. 16, 2005, the "Rising Man" symbol stands in front of the Fridley, Minn., based... FILE - In this Aug.
Vivus Seeks Faster ED Drug: Biobuzz
MOUNTAIN VIEW, Calif. -- For men who want sex now, but um, can't quite get the equipment working fast enough, Vivus might have a new drug for you.
Medtronic-Sponsored Study Indicates Bi-Ventricular Pacing Superior To ...
Pacing the two lower chambers of the heart, or bi-ventricular pacing, prevented cardiac enlargement as compared to only pacing the right ventricle in pacemaker patients with normal pumping hearts, according to results presented from the Pacing to Avoid Cardiac Enlargement trial, a clinical study supported by Medtronic, Inc.
Cerus Corporation Receives FDA Blood Products Advisory Committee...
Main Category: Blood / Hematology Also Included In: Clinical Trials / Drug Trials Cerus Corporation announced that the FDA's Blood Products Advisory Committee rendered a positive opinion on the proposed hemostatic efficacy and safety endpoints for a potential U.S. Phase III clinical trial of the INTERCEPT Blood System for platelets.
Wright Medical Names New Chief Financial Officer
Orthopedic device maker Wright Medical Group Inc. said Monday it named Lance A. Berry senior vice president and chief financial officer, replacing outgoing financial chief John K. Bakewell.
Hologic down as panel advises against breast scans for some women; analyst says sales may drop
Shares of digital mammogram system maker Hologic Inc. fell Tuesday after a government task force recommended that women wait longer before having mammograms, and have the breast examinations less often.
These new screws represent the latest advance in biocomposite material technology that allows CONMED Linvatec to produce the smallest Biocomposite Interference screw available on the market today for primary fixation of ACL and PCL grafts.
Antares Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and...
Antares Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released 2009-11-16 06:19:20 - Antares Pharma, Inc.
Study: Heart device replacements carry risks
Medtronic, St. Jude named in study One in five patients were likely to be hospitalized for complications after heart devices and connecting wires made by Boston Scientific Corp., Medtronic Inc., and St.
Candela Corp. Reports Operating Results
Candela Corp. filed Quarterly Report for the period ended 2009-09-26. Candela Corporation develops, manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies.
Published: Tuesday, November 10, 2009 at 3:06 a.m. Last Modified: Tuesday, November 10, 2009 at 3:30 a.m. Libraries often have interesting displays.
Qiagen 3Q profit jumps on boost in test sales
Medicis Pharmaceutical Corp. posted a third-quarter profit on Wednesday, as sales of its skin products surged, and a research and development charge came off the books.